Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

718 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nevirapine plasma exposure affects both durability of viral suppression and selection of nevirapine primary resistance mutations in a clinical setting.
González de Requena D, Bonora S, Garazzino S, Sciandra M, D'Avolio A, Raiteri R, Marrone R, Boffito M, De Rosa FG, Sinicco A, Di Perri G. González de Requena D, et al. Among authors: di perri g. Antimicrob Agents Chemother. 2005 Sep;49(9):3966-9. doi: 10.1128/AAC.49.9.3966-3969.2005. Antimicrob Agents Chemother. 2005. PMID: 16127084 Free PMC article.
The use of trough ribavirin concentration to predict sustained virological response and haematological toxicity in HIV/HCV-co-infected patients treated with ribavirin and pegylated interferon.
Aguilar Marucco D, Gonzalez de Requena D, Bonora S, Tettoni C, Bonasso M, De Blasi T, D'Avolio A, Sciandra M, Siccardi M, Baietto L, Trentini L, Sinicco A, Cariti G, Di Perri G. Aguilar Marucco D, et al. Among authors: di perri g. J Antimicrob Chemother. 2008 Apr;61(4):919-24. doi: 10.1093/jac/dkn013. Epub 2008 Jan 31. J Antimicrob Chemother. 2008. PMID: 18238889
Tenofovir plasma concentrations according to companion drugs: a cross-sectional study of HIV-positive patients with normal renal function.
Calcagno A, Gonzalez de Requena D, Simiele M, D'Avolio A, Tettoni MC, Salassa B, Orofino G, Bramato C, Libanore V, Motta I, Bigliano P, Orsucci E, Di Perri G, Bonora S. Calcagno A, et al. Among authors: di perri g. Antimicrob Agents Chemother. 2013 Apr;57(4):1840-3. doi: 10.1128/AAC.02434-12. Epub 2013 Feb 4. Antimicrob Agents Chemother. 2013. PMID: 23380733 Free PMC article.
Clinical pharmacology of antiretroviral therapy.
Di Perri G, Sinicco A, Audagnotto S, Gobbi F, Canta F, Marrone R, Bonora S. Di Perri G, et al. New Microbiol. 2004 Apr;27(2 Suppl 1):131-4. New Microbiol. 2004. PMID: 15646076
Key questions in antiretroviral therapy: Italian Consensus Workshop (2005).
Carosi G, Torti C, Andreoni M, Angarano G, Antinori A, Bonora S, Borderi M, Castagna A, Castelli F, Cauda R, Chiodo F, D'arminio-Monforte A, De Luca A, Di Perri G, Dianzani F, Filice G, Galli M, Lazzarin A, Maggiolo F, Maserati R, Mazzotta F, Moroni M, Perno CF, Vullo V. Carosi G, et al. Among authors: di perri g. J Antimicrob Chemother. 2006 Jun;57(6):1055-64. doi: 10.1093/jac/dkl113. Epub 2006 Apr 10. J Antimicrob Chemother. 2006. PMID: 16606637
718 results